| |
| Magyar Diabetes Társaság |
|
| MDT Családorvosi Munkacsoport Regionális Továbbképzése (2017) |
 Rendezvény kezdete: 2017.09.01. | Rendezvény vége: 2017.09.02. |
| Tudományos információ: dr. Gaál Zsolt |
| E-mail: drgzs@josa.hu |
| Szervező: Garhuth Anita |
| E-mail: anita@stand-art.hu |
| Helyszín: 3300 Eger, Szálloda út 1-3., Hotel Eger & Park**** |
| A rendezvény Web oldala: http://stand-art.hu/MDTCSMEger |
Akkreditáció
A rendezvényt belgyógyászok és családorvosok számára szóló továbbképzésként (SZTE-ÁOK/2017.II/00024) a Szegedi Tudományegyetem Továbbképzési Központja akkreditálta (30 pont).
További részletek a kapcsolódó dokumentumok alatt. |
|
|
 |
| |
| Magyar Rehabilitációs Társaság |
|
| 7th Pannonian Symposium on CNS Injury |
| Rendezvény kezdete: 2017.08.30. | Rendezvény vége: 2017.08.31. |
| Helyszín: Pécs, |
| A rendezvény Web oldala: https://pcongress.hu/Congress/index/70 |
The first Pannonian Symposium on CNS Injury in 2000 sought to provide a unique environment for evaluation
of translational research in traumatic brain injury, a pioneering concept at that time.
Contemporary thought now appreciates that communication between basic scientists and clinicians is essential to
improve the relevance and impact of basic science discovery as well as the quality of patient care and
management – a major goal that the Pannonian symposia has embraced for more than 15 years.
Traditions can be measured in decades as well as in centuries. This year the Pannonian Symposium is linked to
celebration of the 650th anniversary of the founding of the University of Pécs, one of the first universities in
Europe, and currently a comprehensive university serving over 30,000 Hungarian and international students.
Appreciating the past – but looking to the future – we embrace this premise as the motto of the 7th Pannonian
Symposium on Central Nervous System Injury, an event also linked to the State of Hungarian Science meeting
on the 1
st of September. The Pannonian Symposium will herald this large scale scientific meeting that will
include the National Brain Program, launched and financed by the Government of Hungary.
Presentations from worldwide experts on brain injury research with a focus on pathobiology and applied clinical
research as well as patient care should help contribute to a better understanding of and ultimately, better
treatments for our brain-injured population.
The organizers believe that - like our previous Pannonian conferences - this symposium will be highly
informative and will inspire collaborative efforts in various areas of research focusing on CNS injury and repair.
The host city of Pécs harbors a special medieval atmosphere, with the majority of the city included in the
World's Cultural Heritage designation (UNESCO). Pécs is also a colorful and exciting Central-European city
that served as the European Capital of Culture in 2010.
As hosts of this symposium we look forward to the 17th anniversary of our first meeting, to welcome you again
to Pécs, anticipating that this meeting will again be an academic and social success, while commemorating the
founding of our University! |
|
|
|
| |
| Magyar Endokrinológiai és Anyagcsere Társaság |
|
| XIV CAPRI CONFERENCE "Novel Mechanisms and clinical aspects of cardiovascular disorders |
| Rendezvény kezdete: 2011.04.15. | Rendezvény vége: 2011.04.17. |
| Szakterület(ek): Hipertónia, Kardiológia |
| Tudományos információ: Aristea International |
| Címe: Italy, 00198 Roma, Via Lima, 31 |
| Tel: +39 06 845431 |
| Fax: +39 06 84543700 |
| E-mail: roma@aristea.com |
| Szervező: Aristea International |
| Munkahely neve: Aristea |
| Címe: Italy, 00198 Roma, Via Lima, 31 |
| Tel: +39 06 845431 |
| Fax: +39 06 84543700 |
| E-mail: roma@aristea.com |
| Helyszín: www.capriconference.org, XIV CAPRI CONFERENCE "Novel Mechanisms and clinical aspects of cardiovascular disorders" |
The Capri Conference is an established and an international event where join together to develop and deal with the multiple and different discoveries that surround the Cardiovascular world.
This year our invited experts will discuss on various issues: from the management of Thromboembolism to the Atrial fibrillation, from new Antiplatelet Agents to Genetic aspects of Cardiomyopathies and to the latest guide line for the treatment of hypertension, heart and kidney.
The following are some of the Hot Topics:
• RAAS and metabolic syndrome
• Antialdosteronic therapy
• Lipids and cv events in the year 2011 – Residual risk
• New advances in the knowledge of renin
• Prevention/protection of MAU in hypertension
• BP targets in hypertension
• RAS and plaque stability
• RAS and vascular remodeling
• AT2 receptor agonists
• Prevention of CV disease in diabetes
• Prorenin/renin receptors
|
|
|
|
| |
| Magyar Endokrinológiai és Anyagcsere Társaság |
|
| XIV CAPRI CONFERENCE "Novel Mechanisms and clinical aspects of cardiovascular disorders |
| Rendezvény kezdete: 2011.04.15. | Rendezvény vége: 2011.04.17. |
| Szakterület(ek): Hipertónia, Kardiológia |
| Tudományos információ: Aristea International |
| Címe: Italy, 00198 Roma, Via Lima, 31 |
| Tel: +39 06 845431 |
| Fax: +39 06 84543700 |
| E-mail: roma@aristea.com |
| Szervező: Aristea International |
| Munkahely neve: Aristea |
| Címe: Italy, 00198 Roma, Via Lima, 31 |
| Tel: +39 06 845431 |
| Fax: +39 06 84543700 |
| E-mail: roma@aristea.com |
| Helyszín: www.capriconference.org, XIV CAPRI CONFERENCE "Novel Mechanisms and clinical aspects of cardiovascular disorders" |
The Capri Conference is an established and an international event where join together to develop and deal with the multiple and different discoveries that surround the Cardiovascular world.
This year our invited experts will discuss on various issues: from the management of Thromboembolism to the Atrial fibrillation, from new Antiplatelet Agents to Genetic aspects of Cardiomyopathies and to the latest guide line for the treatment of hypertension, heart and kidney.
The following are some of the Hot Topics:
• RAAS and metabolic syndrome
• Antialdosteronic therapy
• Lipids and cv events in the year 2011 – Residual risk
• New advances in the knowledge of renin
• Prevention/protection of MAU in hypertension
• BP targets in hypertension
• RAS and plaque stability
• RAS and vascular remodeling
• AT2 receptor agonists
• Prevention of CV disease in diabetes
• Prorenin/renin receptors
|
|
|
|
